PA
AGRX

Pinnacle Associates’s Agile Therapeutics AGRX Stock Holding History

Pinnacle Associates’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-10
Closed -$50K – 744
2019
Q4 		$50K Buy
+10
New +$34.9K ﹤0.01% 707
2017
Q2 		– Sell
-5
Closed -$32K – 694
2017
Q1 		$32K Hold
5
– – ﹤0.01% 654
2016
Q4 		$57K Sell
5
-20
-80% -$280K ﹤0.01% 630
2016
Q3 		$350K Sell
25
-13
-34% -$186K 0.01% 521
2016
Q2 		$572K Sell
38
-1
-3% -$13.7K 0.01% 450
2016
Q1 		$484K Buy
39
+15
+63% +$194K 0.01% 461
2015
Q4 		$471K Sell
24
-1
-4% -$15.8K 0.01% 468
2015
Q3 		$334K Hold
25
– – 0.01% 506
2015
Q2 		$426K Hold
25
– – 0.01% 487
2015
Q1 		$460K Buy
+25
New +$438K 0.01% 470

Other funds holding AGRX

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EP
Eversept Partners New York $1.52B AUM 121.13% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return